Dianthus EVP, Head of R&D Simrat Randhawa sells USD 2.45 million in common sharesPUBT·Sep 3 at 08:31 PMDNTH-1.92%
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DNTH Stock NewsStockTitan·Sep 2 at 01:00 PMDNTH-1.92%
Dianthus Therapeutics CEO to join Citi Biopharma Back to School fireside chatPUBT·Sep 1 at 12:06 PMDNTH-1.92%
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week High - Still a Buy?Market Beat·Aug 20 at 08:00 AMDNTH-1.92%UBS-0.42%
Simon Read Sells 2,778 Shares of Dianthus Therapeutics (NASDAQ:DNTH) StockMarket Beat·Aug 19 at 11:22 PMDNTH-1.92%
Dianthus Therapeutics director Simon Read disposes of common shares worth $326,148.9PUBT·Aug 19 at 10:03 PMDNTH-1.92%
Handelsbanken Fonder AB Invests $1.49 Million in Dianthus Therapeutics, Inc. $DNTHMarket Beat·Aug 19 at 08:56 AMDNTH-1.92%
Cross-Border Realignments and Domestic Pivots: The Evolving Global Narrative Behind 10 Diverse EquitiesGlobal Report·Aug 18 at 10:12 AMBACHY+0.11%DNTH-1.92%
Dianthus Therapeutics (DNTH) Climbed, What Is Behind The Move?Simplywall·Aug 13 at 07:48 AMDNTH-1.92%
Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 jutaPUBT·Aug 11 at 09:09 PMDNTH-1.92%
Dianthus’ New Dual-Target Autoimmune Drug DNTH312 Could Be A Game Changer For DNTHSimplywall·Aug 8 at 03:56 AMDNTH-1.92%
Dianthus Therapeutics CEO Marino Garcia reports disposal of 166,000 common shares worth $17.97 millionPUBT·Aug 7 at 10:31 PMDNTH-1.92%
Truist Financial Raises Dianthus Therapeutics (NASDAQ:DNTH) Price Target to $128.00Market Beat·Aug 6 at 04:24 PMDNTH-1.92%
Dianthus Therapeutics (NASDAQ:DNTH) Posts Earnings Results, Misses Expectations By $0.05 EPSMarket Beat·Aug 5 at 12:11 AMDNTH-1.92%
Dianthus Maintained at Buy as Strong Cash Runway and DNTH312 Pipeline Potential Support Unchanged $125 Price TargetTip Ranks·Aug 4 at 09:45 PMDNTH-1.92%
